Volume 3, Number 1, December 2008

Is Immunotherapy an Option for my Patients with Severe Seasonal Allergic Rhinitis?
Lisa Dixon, Susan Smith

Severe seasonal allergic rhinitis (hayfever) has a significant impact on sufferers’ quality of life and productivity, and can be a challenging condition to manage in primary care. As a majority of these patients have poor or only partial symptom control in primary care, they may be suitable for referral to secondary care. Some of these patients may be appropriate for treatment with specific allergen immunotherapy and this article reviews the impact of severe seasonal allergic rhinitis and highlights recent data on the effectiveness of sublingual immunotherapy.

View full PDF article (open in new window)
Email this article